Board Review & Recertification Course

Whether you are preparing for board recertification or looking for a comprehensive clinical update, MSHO's Board Review Course provides an in-depth review of key topics in hematology and oncology. 

more information

Healthcare Bill Tracking

Track Healthcare Legislation Happening in Michigan!

Follow legislation that MSHO is actively monitoring that may impact you and your patients. 

more information

Previous Next

Advocacy

MSHO continuously contacts legislators, provides comments to policy makers, and collaborates with payers on issues of concern to those delivering care to cancer patients.

more information

Education

It is important that our members are aware of meetings, webinars, and other educational opportunities specifically designed to address the complexities of cancer care.

more information

Research

MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan’s cancer patients.

more information

MSHO Foundation

The MSHO Foundation is a 501c3 organization which was formed in 2011 to address the growing educational needs of hematology and oncology professionals in Michigan.

more information

Job Board

MSHO offers our members an opportunity to share current job openings or post your resume as a job seeker on our website. Click here to view job openings, posted resumes, or to create a new post.

more information

Upcoming Events view all events

 July 2026 
SMTWTFS
   1234
567891011
12131415161718
19202122232425
262728293031 
Sat
22
2026
August 22, 2026

Board Review & Re-Certification Course

Somerset Inn, Troy

view event details
Sat
26
2026
September 26 - 27, 2026

MSHO Annual Meeting

Boyne Mountain Grand Lodge & Spa, Boyne Falls

view event details
Sat
26
2026
September 26, 2026

Update in Hematology and Oncology

SAVE THE DATE!

Boyne Mountain Resort, Boyne Falls

view event details

Latest News view all news

Urge Congress to Take Action and Stop the Implementation of the Trump Administration Rule to Change Federal Grant Making Process
07/16/2026

Urge Congress to Take Action and Stop the Implementation of the Trump Administration Rule to Change Federal Grant Making Process

Michigan Legislature Invests $1 Million in YesRx to Put No-Cost Cancer Medication in the Hands of Patients Statewide
07/16/2026

Michigan Legislature Invests $1 Million in YesRx to Put No-Cost Cancer Medication in the Hands of Patients Statewide

FDA Approves Celcuity's REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
07/16/2026

FDA Approves Celcuity's REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

FDA approves AstraZeneca's Imfinzi™ (durvalumab) with Bacillus Calmette-Guerin for high-risk non-muscle invasive bladder cancer
05/29/2026

FDA approves AstraZeneca's Imfinzi™ (durvalumab) with Bacillus Calmette-Guerin for high-risk non-muscle invasive bladder cancer

Corporate Sponsors view all sponsors